z-logo
Premium
Cefonicid kinetics in subjects with normal and impaired renal function
Author(s) -
Blair Andrew D,
Maxwell Barbara M,
Forland Steve C,
Jacob Leonard,
Cutler Ralph E
Publication year - 1984
Publication title -
clinical pharmacology and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.941
H-Index - 188
eISSN - 1532-6535
pISSN - 0009-9236
DOI - 10.1038/clpt.1984.115
Subject(s) - renal function , hemodialysis , volume of distribution , medicine , urology , pharmacokinetics
Cefonicid is a cephalosporin with a longer t½ than currently available cephalosporins. Cefonicid kinetics after an intravenous dose of 7.5 mg/kg were followed in four groups of subjects: group 1, four subjects with normal creatinine clearance (Cl cr > 80 ml/min); group II, seven subjects with mild renal insufficiency (Cl cr 50 to 80 ml/min); group III, five subjects with moderate to severe renal impairment (Cl cr 8 to 49 ml/min); and group IV, five subjects with end‐stage renal disease who were receiving maintenance hemodialysis (Cl cr < 8 ml/ml). Cefonicid volume of distribution ranged from 6.9% to 17.6% body weight but was not related to Cl cr . Elimination t½ was 4.6 ± 0.7 hr in group I, 6.0 ± 2.7 hr in group II, 25.6 ± 14.0 hr in group III, and 65.3 ± 43.6 hr in group IV. There was a strong correlation between plasma cefonicid clearance and Cl cr . Nonrenal clearance did not change with decreasing Cl cr . Hemodialysis clearance calculated from plasma concentrations and recovery in dialysate was 2.5 ± 0.9 ml/min. These kinetic parameters were used to formulate dosage regimens for patients with renal impairment. Clinical Pharmacology and Therapeutics (1984) 35 , 798–803; doi: 10.1038/clpt.1984.115

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom